ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ 4
4 · ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ · Filed Oct 21, 2014
Insider Transaction Report
Form 4
Chambers Medical Foundation
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2014-10-17$3.51/sh+20,000$70,200→ 20,000 total - Exercise of In-Money
Warrant to purchase common stock
2014-10-17−20,000→ 0 totalExercise: $3.51From: 2014-06-19Exp: 2016-12-18→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Based on information included in a Schedule 13D/A filed with the SEC on September 21, 2011 by the Chambers Medical Foundation the Reporting Person beneficially owned 276,268 shares of common stock prior to the transaction.